XML 30 R1.htm IDEA: XBRL DOCUMENT v3.25.0.1

Submission	Feb. 07, 2025
Submission [Line Items]
Central Index Key	0000818686
Registrant Name	Teva Pharmaceutical Industries Limited
Form Type	S-3
Submission Type	S-3ASR
Fee Exhibit Type	EX-FILING FEES

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2

+ Details

Name:	dei_EntityCentralIndexKey
Namespace Prefix:	dei_
Data Type:	dei:centralIndexKeyItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2

+ Details

Name:	dei_EntityRegistrantName
Namespace Prefix:	dei_
Data Type:	xbrli:normalizedStringItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ffd_FeeExhibitTp
Namespace Prefix:	ffd_
Data Type:	ffd:feeExhibitTypeItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ffd_FormTp
Namespace Prefix:	ffd_
Data Type:	ffd:submissionTypeItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ffd_SubmissionLineItems
Namespace Prefix:	ffd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ffd_SubmissnTp
Namespace Prefix:	ffd_
Data Type:	ffd:submissionTypeItemType
Balance Type:	na
Period Type:	duration